Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Carlo Salvarani and Pamela Mancuso.
Carlo Salvarani
Connection Strength
1.019
Pamela Mancuso
  1. Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1215-1222.
    View in: PubMed
    Score: 0.229
  2. Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy. Arthritis Rheumatol. 2021 01; 73(1):48-52.
    View in: PubMed
    Score: 0.229
  3. Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu et al. Ann Rheum Dis. 2020 Jul 06.
    View in: PubMed
    Score: 0.223
  4. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study. Ann Rheum Dis. 2020 07; 79(7):986-988.
    View in: PubMed
    Score: 0.221
  5. Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy. Rheumatology (Oxford). 2021 10 09; 60(SI):SI25-SI36.
    View in: PubMed
    Score: 0.061
  6. Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation. Crit Care. 2020 09 29; 24(1):589.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.